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Tissue resistance to insulin action results from abnormalities affecting the insulin signalling cascade. This intricate molecular pathway, controlled by positive and negative regulators, affects most major areas of metabolism (Fig. 1) . Our growing comprehension of the complexity of these biochemical mechanisms makes it difficult to ascertain exactly what is happening in the insulin-resistant patient.
Tribbles are a family of signal-regulating proteins shown to coordinate the activation and the suppression of different pathways [1] . In cells, tribbles play a key role in determining cell fate while responding to environmental challenges [1] . In particular, mammalian tribbles homologue 3 (TRIB3), the best-studied member of the mammalian tribbles family, has been reported to protect cells from starvation-mediated apoptosis [2] and to impact negatively on AKT/protein kinase B (PKB) activation [3, 4] . Indeed, TRIB3 has been reported by most [3, 5] , though not all [6] studies to impair insulin action by binding and inhibiting AKT/PKB phosphorylation in murine models of diabetes. These same studies have provided initial evidence that increasing levels of TRIB3 may contribute to the onset of insulin resistance in mice [3, 5] .
In humans, the functional Q84R polymorphism in TRB3 (also known as TRIB3) has been identified, and is associated with insulin resistance [4, 7] and type 2 diabetes [8] . This gain-of-function polymorphism is accompanied by enhanced inhibition of insulin signalling and AKT/PKB activation in different tissues, including the beta cells [3, 4, 9] . Indeed, the TRIB3 Q84R polymorphism has been found to associate with defective insulin secretion in addition to insulin resistance [8] . Thus, TRIB3 adds to the growing list of molecules which, through tightly regulated action, enable normal beta cell function and insulin signalling in humans (Fig. 2) . Such molecules also now include phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes-15 (PEA-15 [also known as PED]) [10] and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) [11] as well as IRS1 [12] . However, the discovery of TRIB3 action on insulin signalling has highlighted the specific significance of AKT/PKB for beta cell function within the IRS/phosphoinositide-3 kinase (PI3K)/AKT/PKB pathway. Consistently, independent studies in transgenic mice in which a dominant-negative mutation results in a defective AKT/PKB pathway selectively in beta cells have shown defective insulin exocytosis resulting from abnormalities beyond Ca 2+ influx [13] . The biological relevance of the TRB3 Q84R polymorphism has been extensively demonstrated both in vivo and in vitro and the information available clearly indicates that it affects both insulin action and secretion. Despite this strong biological and clinical candidacy, TRB3 was not identified in the most recent genome-wide association studies, which identified mainly variants proposed to affect insulin secretion and beta cell function [14] . This is the case for most other genes and variants impacting on insulin action, raising the question: where are the type 2 diabetes genes that affect insulin resistance [15] ? Different hypotheses to explain this failure and strategies to improve the outcome of future gene-hunting studies have been extensively reviewed elsewhere [9] . It is interesting to underline, however, that the association of the TRB3 Q48R variant with type 2 diabetes is mainly attributable to early onset of the disease [4] , clearly indicating that reduced heterogeneity in study populations may enable the identi- fication of genetic effects that would otherwise have been missed. Related to this same problem, the study by Oberkofler and co-workers [16] published in this issue of Diabetologia raises, though only partially addresses, two additional intriguing issues, both of which very much deserve consideration in future studies.
First, the paper by Oberkofler et al. shows, for the first time, aberrant TRB3 gene expression in insulin-resistant obese human individuals. Despite the lack of any direct evidence supporting the genetic nature of the defect observed in these obese individuals, the data shown in this report are not inconsistent with this possibility. Indeed, the analysis of the transcriptional network regulating TRIB3 levels is far too limited to enable any mechanistic conclusion on the causes of aberrant TRIB3 production in the patients. On the other hand, the design of previous genome-wide association studies might have biased the scans against genes that increase diabetes risk through effects on BMI [15] . Once again, careful stratification of the study population will be necessary to rigorously address the origin of aberrant expression of TRB3 among the obese individuals in future genetic investigations.
Second, the study by Oberkofler and co-workers addresses the need for recording dietary habits and for investigating the epigenetic regulation to ascertain, respectively, the non-genetic and genetic contribution of alleles with relatively small effects. At least in part, obesity is an environmentally determined disorder caused by excessive nutrient intake. Current evidence indicates that nutrients may impact on genetic effects [17] and, indeed, gene-diet interactions have already been reported to modulate the risk of type 2 diabetes in some cases [18] [19] [20] . Based on this evidence, these effects will need to be taken into account in future studies in order to unravel the contribution to type 2 diabetes risk of genes with small effects or relatively rare variants. Nutritional interventions have been reported to have significant impact on TRIB3 function [21] . In addition, different diet components are known to be capable of inducing epigenetic changes at different genes, including TRIB3 [22] . Indeed, the importance of considering epigenetic modifications for unravelling the genetic architecture of type 2 diabetes is receiving increasing attention [23] . Thus, as for other established or candidate risk genes for type 2 diabetes, the potential significance of the epigenetic regulation of TRB3 gene function to insulin resistance and type 2 diabetes deserves further investigation in the future.
Unravelling the genetics of type 2 diabetes may appear a tantalising goal at this time. While certainly challenging, it is also potentially very rewarding, offering better strategies to treat and, maybe, to prevent type 2 diabetes in the 21st century.
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